⌘K

Home/Filings/4/0000905718-21-000994

4//SEC Filing

Dubin Michael F 4

Accession 0000905718-21-000994

CIK 0001708331other

View on SEC.gov Company Profile

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 6:11 PM ET

Size

5.2 KB

Accession

0000905718-21-000994

Insider Transaction Report

Form 4

Period: 2021-07-26

Virpax Pharmaceuticals, Inc.VRPX

Dubin Michael F

Director

Transactions

Award
Stock Option (right to buy)
2021-07-26+20,225→ 20,225 total
Exercise: $4.32From: 2022-07-26Exp: 2031-07-26→ Common Stock, par value $0.00001 per share (20,225 underlying)

Documents

1 file

4
virpax_fm4jul262021.xmlPrimary

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1

filerCIK 0001876497

Filing Metadata

Form type: 4
Filed: Aug 4, 8:00 PM ET
Accepted: Aug 5, 6:11 PM ET
Size: 5.2 KB

View on SEC.gov